Product

What if you could anticipate clinical trial outcomes months ahead of time?

STAT Trials Pulse is the most advanced early warning system for clinical trial updates, trusted by the leading hedge funds, pharmaceutical companies, and biotech firms.
Phone and Laptop showing the Stat Trials Pulse dashboard.
TRUSTED BY

Impact

Be the first to know about important shifts in clinical trials including roadblocks, results, recruitment activity, regulatory updates, timeline delays, and more.
Customizable
Watchlists
Monitor updates across clinical trials registries, scientific papers, and press releases for organizations, conditions, and interventions you care about.
graphic of binoculars
Smart
Alerts
Get real-time notifications for your watchlists and followed trials, along with contextual interpretation for each new update.
Global
Trends
Discover the highest impact activity across drug development and regulatory approval processes.
Email
Briefing
Receive a daily digest with the most important updates in your corner of the clinical trials landscape.
Coverage across 22,000 organizations, 26,000 interventions, and 5,800 diseases.
Book Demo

ALGORITHMS VETTED BY EXPERTS

Specialized algorithms developed to replicate the rigorous research process of biotech journalists.
Headshot of Adam Feuerstein, STAT News
Adam Feuerstein, STAT News
“STAT Trials Pulse is an essential platform for anyone who needs to find, track and analyze clinical trials.”
Headshot of Kate Sheridan, STAT News
Kate Sheridan, STAT News
“The algorithm’s ability to surface otherwise invisible trends is truly remarkable.”
Headshot of Matt Herper, STAT News
Matt Herper, STAT News
"STAT Trials Pulse provides a new way to find and track changes in the studies that matter to you."

PREPARE YOUR NEXT MOVE

Join the new establishment of data-driven life sciences professionals who see ahead of the news.
There are over 6,800 clinical trials updates every day. Trying to analyze these changes and look for outliers is a staggering undertaking — but is also essential for investment firms and pharmaceutical companies making strategic decisions.
"The platform allows us to stay on top of clinical trials while understanding what is driving various shifts so we can prepare our next moves."
Analyst, Biopharma
$25B AUM Hedge Fund
“STAT Trials Pulse stands out by its ability to surface and classify updates in trial records – not only does it tell us that something changed, it tells me exactly what that change is. ”
Director, Competitive Intelligence
Fortune 500 Pharmaceutical Company
Screenshot of a graph showing detailed information.